nach oben

Sleep and Breathing

Erschienen in:

11.01.2017 | Sleep Breathing Physiology and Disorders • Short Communication

Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea

verfasst von: Anthony J. Grady, Jane S. Hankins, Brent Haberman, Robert Schoumacher, Rose Mary Stocks

Erschienen in: Sleep and Breathing | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

While hydroxyurea is the mainstay of treatment for many of the comorbidities associated with sickle cell disease, its effect on obstructive sleep apnea has not been fully investigated. The purpose of this project is to help characterize the effects of hydroxyurea on obstructive sleep apnea in children with sickle cell disease and determine its therapeutic role in the condition.

Methods

Chart review was conducted on two pediatric patients with sickle cell disease who experienced resolution of obstructive sleep apnea following hydroxyurea administration.

Results

After undergoing approximately 11 months of hydroxyurea therapy, sleep apnea symptoms improved and obstructive sleep apnea resolution was confirmed by repeat polysomnography in both cases. This resolution was largely secondary to a reduction in the obstructive component of the apnea hypopnea index, highlighting a previously unreported association.

Conclusions

As adenotonsillectomy is associated with significant risks in patients with sickle cell disease, it appears reasonable to consider a period of observation for improvement of obstructive sleep apnea following hydroxyurea administration rather than directly proceeding with surgery.

Hankins JS, Verevkina NI, Smeltzer MP, Wu S, Aygun B, Clarke DF (2014) Assessment of sleep-related disorders in children with sickle cell disease. Hemoglobin 38(4):244–251. doi:10.3109/03630269.2014.919941 CrossRefPubMed

Rosen CL, Debaun MR, Strunk RC, Redline S, Seicean S, Craven DI, Gavlak JC, Wilkey O, Inusa B, Roberts I, Goodpaster RL, Malow B, Rodeghier M, Kirkham FJ (2014) Obstructive sleep apnea and sickle cell anemia. Pediatrics 134(2):273–281. doi:10.1542/peds.2013-4223 CrossRefPubMedPubMedCentral

Strauss TBA, Sin SMS, Marcus CLMF, Mason TBAMDP, McDonough JMMS, Allen JLMD, Caboot JBMD, Bowdre CYP, Jawad AFP, Smith-Whitley KMD, Ohene-Frempong KMD, Pack AIMDP, Arens RMD (2012) Upper airway lymphoid tissue size in children with sickle cell disease. Chest 142(1):94–100CrossRefPubMedPubMedCentral

Minter KR, Gladwin MT (2001) Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med 164(11):2016–2019. doi:10.1164/ajrccm.164.11.2104101 CrossRefPubMed

Needleman JP, Setty BN, Varlotta L, Dampier C, Allen JL (1999) Measurement of hemoglobin saturation by oxygen in children and adolescents with sickle cell disease. Pediatr Pulmonol 28(6):423–428CrossRefPubMed

Duke RL, Scott JP, Panepinto JA, Flanary VA (2006) Perioperative management of sickle cell disease children undergoing adenotonsillectomy. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 134(3):370–373. doi:10.1016/j.otohns.2005.11.001 CrossRef

Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC (2005) Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 106(7):2269–2275. doi:10.1182/Blood-2004-12-4973 CrossRefPubMedPubMedCentral

Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E (1996) Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 88(6):1960–1964PubMed

Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet (London, England) 377(9778):1663–1672. doi:10.1016/s0140-6736(11)60355-3 CrossRef

10.

Narang I, Dhanju S, Amin R, Al-Saleh S, Kadman G, Lai D (2014) Impact of hydroxyurea in sleep disordered breathing in children with sickle cell disease. Sleep 37:A336

11.

Narang I, Kadmon G, Lai D, Dhanju S, Kirby-Allen M, Odame I, Amin R, Lu Z, Al-Saleh S (2015) Higher nocturnal and awake oxygen saturations in children with sickle cell disease receiving hydroxyurea therapy. Annals of the American Thoracic Society 12(7):1044–1049. doi:10.1513/AnnalsATS.201410-473OC CrossRefPubMed

12.

Okoli K, Irani F, Horvath W (2009) Pathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies. Med Hypotheses 72(5):578–580. doi:10.1016/j.mehy.2008.12.012 CrossRefPubMed

13.

Salles C, Ramos RT, Daltro C, Nascimento VM, Matos MA (2009) Association between adenotonsillar hypertrophy, tonsillitis and painful crises in sickle cell disease. J Pediatr 85(3):249–253. doi:10.2223/JPED.1898

14.

Everett MT (1979) The cause of tonsillitis. The Practitioner 223(1334):253–259PubMed

15.

Finch PMD, Stocks RMMDP, Smeltzer MPMS, Kimble AFNP, Schoumacher RMD, Hankins JSMDMS (2013) Effects of adenotonsillectomy on polysomnographic parameters in children with sickle cell disease. Pediatr Blood Cancer 60(7):E26–E28CrossRefPubMed

16.

Ijaduola GT, Akinyanju OO (1987) Chronic tonsillitis, tonsillectomy and sickle cell crises. J Laryngol Otol 101(5):467–470CrossRefPubMed

17.

Gozal D, Serpero LD, Sans Capdevila O, Kheirandish-Gozal L (2008) Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 9(3):254–259. doi:10.1016/j.sleep.2007.04.013 CrossRefPubMed

18.

Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7(1):35–51CrossRefPubMed

19.

Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, Snow A, Bhattacharjee R, Gozal D (2009) Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 135(5):1142–1149. doi:10.1378/chest.08-2102 CrossRefPubMed

20.

Zhang D, Xu C, Manwani D, Frenette PS (2016) Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood 127(7):801–809. doi:10.1182/blood-2015-09-618538 CrossRefPubMedPubMedCentral

21.

Lemonne N, Charlot K, Waltz X, Ballas SK, Lamarre Y, Lee K, Hierso R, Connes C, Etienne-Julan M, Romana M, Connes P (2015) Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia. Haematologica 100(10):e383–e386. doi:10.3324/haematol.2015.130435 CrossRefPubMedPubMedCentral

22.

Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8(12):1383–1389. doi:10.1038/nm799 CrossRefPubMed

23.

Niu X, Nouraie M, Campbell A, Rana S, Minniti CP, Sable C, Darbari D, Dham N, Reading NS, Prchal JT, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR (2009) Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One 4(11):e7956. doi:10.1371/journal.pone.0007956 CrossRefPubMedPubMedCentral

24.

Rana S, Houston PE, Wang WC, Iyer RV, Goldsmith J, Casella JF, Reed CK, Rogers ZR, Waclawiw MA, Thompson B (2014) Hydroxyurea and growth in young children with sickle cell disease. Pediatrics 134(3):465–472. doi:10.1542/peds.2014-0917 CrossRefPubMedPubMedCentral

25.

Saboisky JP, Butler JE, Gandevia SC, Eckert DJ (2012) Functional role of neural injury in obstructive sleep apnea. Front Neurol 3:95. doi:10.3389/fneur.2012.00095 CrossRefPubMedPubMedCentral

26.

Loredo JS, Ancoli-Israel S, Kim EJ, Lim WJ, Dimsdale JE (2006) Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep 29(4):564–571CrossRefPubMed

27.

Aljadeff G, Gozal D, Bailey-Wahl SL, Burrell B, Keens TG, Ward SL (1996) Effects of overnight supplemental oxygen in obstructive sleep apnea in children. Am J Respir Crit Care Med 153(1):51–55. doi:10.1164/ajrccm.153.1.8542162 CrossRefPubMed

28.

Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, Mitchell RB, Amin R, Katz ES, Arens R, Paruthi S, Muzumdar H, Gozal D, Thomas NH, Ware J, Beebe D, Snyder K, Elden L, Sprecher RC, Willging P, Jones D, Bent JP, Hoban T, Chervin RD, Ellenberg SS, Redline S (2013) A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 368(25):2366–2376. doi:10.1056/NEJMoa1215881 CrossRefPubMedPubMedCentral

29.

Chervin RD, Ellenberg SS, Hou X, Marcus CL, Garetz SL, Katz ES, Hodges EK, Mitchell RB, Jones DT, Arens R, Amin R, Redline S, Rosen CL (2015) Prognosis for spontaneous resolution of OSA in children. Chest 148(5):1204–1213. doi:10.1378/chest.14-2873 CrossRefPubMedPubMedCentral

30.

Li AM, Au CT, Ng SK, Abdullah VJ, Ho C, Fok TF, Ng PC, Wing YK (2010) Natural history and predictors for progression of mild childhood obstructive sleep apnoea. Thorax 65(1):27–31. doi:10.1136/thx.2009.120220 CrossRefPubMed

Titel: Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea
verfasst von: Anthony J. Grady
Jane S. Hankins
Brent Haberman
Robert Schoumacher
Rose Mary Stocks
Publikationsdatum: 11.01.2017
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 3/2017
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-017-1458-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

26.04.2024 | Hüft-TEP | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea

Abstract

Background

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Update Innere Medizin

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Drug-induced sleep endoscopy with target-controlled infusion using propofol and monitored depth of sedation to determine treatment strategies in obstructive sleep apnea

Toward a functional definition of ankyloglossia: validating current grading scales for lingual frenulum length and tongue mobility in 1052 subjects

The effect of intermittent fasting during Ramadan on sleep, sleepiness, cognitive function, and circadian rhythm

“Make OSA great again” Report from the 113th American Thoracic Society International Conference (2017) in Washington DC

The effect on snoring of using a pillow to change the head position

The long-term effects of mandibular advancement splint on cardiovascular fitness and psychomotor performance in patients with mild to moderate obstructive sleep apnea: a prospective study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Update Innere Medizin